Dana–Farber Cancer Institute

Recent research reveals that unintentional weight loss significantly raises the risk of cancer diagnosis within a year. The study, which evaluated over 157,000 health professionals, emphasizes the necessity of consulting a doctor for unexpected weight loss to facilitate early detection and treatment of cancer, despite the study’s demographic limitations.A study from the Dana-Farber Cancer Institute indicates that unintentional weight loss is linked to a heightened risk of receiving a cancer diagnosis within the next…

In a study out this week, scientists describe a novel experimental pill that may be able to help patients with a difficult-to-treat form of leukemia. Nearly half of patients in the Phase I trial responded to the treatment, called revumenib, while about a third experienced a complete remission of their cancer. More research will be needed to confirm its effectiveness, however.Revumenib is being developed by the company Syndax. It’s meant to work by inhibiting a protein called menin, which seems to play an important role in…